Document:

exv10w45

Exhibit 10.45

Amendment to Lease Agreement

     This Amendment to Lease Agreement (“AGREEMENT”) made and entered into this 27th day of January
2009, by and between RED GATE III LLC (“LANDLORD”) and ENTREMED, INC. (“TENANT”).

WITNESSETH:

     Whereas, the LANDLORD and TENANT entered into a certain lease (“LEASE”) dated June 10, 1998,
covering 46,267 square feet of space (“PREMISES”) located in 9640 Medical Center Drive, Rockville,
Maryland (“BUILDING”).

     Now, therefore, the parties hereto, intending to be legally bound, do covenant and agree as
follows:

     1. The TENANT desires and the LANDLORD agrees to remove 37,713 square feet of space from
LEASE, thus decreasing the total square footage to 8,554 square feet (core factor included).

     2. (a) The TENANT shall occupy the first floor of Building only and shall have use of the
loading dock and reception area.

     (b) The TENANT shall have access to use a designated laboratory bench and hood located
in Rooms 302 and 303 and the -70 degree refrigerators located on the third floor, access to
the basement including a designated portion of the vivarium and the file room. The TENANT
agrees that such areas for access can be changed if the parties subsequently determine a
different location within the building is more advantageous or cost-effective to both
parties. The TENANT agrees that its use of these areas will terminate when the Landlord
enters into a lease with a primary tenant who desires to exclusively occupy such areas. The
TENANT may independently negotiate a shared used arrangement with such primary tenant.

     (c) The TENANT shall continue to have access (i) to the computer server room located
on the second floor and (ii) all other areas of the building solely to complete its
wind-down and cleanup activities, which TENANT agrees to complete as soon as practicable.

     (d) The TENANT shall pay utilities in areas referenced in Paragraph 2 Section a, b,
and c. TENANT shall be responsible to shut off utilities in all unused areas.

     3. The TENANT desires and LANDLORD agrees to extend LEASE for a period of twelve (12) months
commencing March 1, 2009 and terminating February 28, 2010.

     4. The annual Minimum Rent for the Premises shall be in the amount of One Hundred Ninety Five
Thousand Four Hundred Fifty Eight and 90/100 Dollars ($195,458.90). Payable without deduction or
set off in equal monthly installments of Sixteen Thousand Two Hundred Eighty Eight and 24/100
Dollars ($16,288.24).

     5. As per Section 4 of Lease Agreement, The Minimum Rent shall be increased at the end of each
lease year during the term by three percent (3%) of the rent then being paid.

     6. The TENANT’S pro rata share of the real estate taxes shall be 18.5%

     Ratification of LEASE: Except as expressly modified or amended by this AGREEMENT, all terms,
covenants and conditions of the LEASE shall remain the same.

     In witness whereof, LANDLORD and TENANT have caused this AGREEMENT to be executed as of this
27th day of January 2009, and do hereby declare this AGREEMENT to be binding on them, their
respective successors and assigns.

	 	 	 
	WITNESS:

	 	LANDLORD:
	 

	 	RED GATE III LLC
	 
	 	 
	 
	 	 
	 

	 	 
	 

	 	By: William M. Rickman
	 
	 	 
	WITNESS:

	 	TENANT:
	 

	 	ENTREMED, INC.
	 
	 	 
	 
	 	 
	 

	 	 
	 

	 	By: Cynthia W. Hu, COOexv10w46

Exhibit 10.46

EMPLOYMENT AGREEMENT

     This EMPLOYMENT AGREEMENT (“Agreement”) is made effective as of January 1, 2009, by
and between ENTREMED, INC., a Delaware corporation having its principal office at 9640 Medical
Center Drive, Rockville, MD 20850 (the “Company”) and Kathy Wehmeir-Davis (the
“Executive”).

     FOR AND IN CONSIDERATION of the mutual premises, agreements and covenants contained herein,
the parties hereto, intending to be legally bound, do hereby agree as follows:

1. Employment; Position and Duties.

Subject to the terms hereof, the Company hereby agrees to employ Executive during the Term (as
hereafter defined) to act as, and to exercise all of the powers and functions of its Principal
Accounting Officer, and to perform such acts and duties and to generally furnish such services to
the Company and its subsidiaries (if any) as is customary for a senior management person with a
similar position in like companies. Among other things, and subject to change at the discretion of
the Executive Committee of the Board of Directors (the “Board”), the Executive shall be
responsible for providing direction to and management of the Company’s finance, accounting,
treasury, Securities and Exchange Commission reporting and other administration activities.
Executive shall report directly to the Executive Committee of the Board or such other senior
officers of the Company as designated by the Executive Committee, and have such other powers,
duties and responsibilities as the Executive Committee shall from time to time reasonably
prescribe. Executive will be a member of the Company’s Senior Management Team. Executive hereby
agrees to accept such employment and shall perform and discharge faithfully, diligently, and to the
best of her abilities such duties and responsibilities and shall devote sufficient working time and
efforts to the business and affairs of the Company and its subsidiaries.

2. Place of Employment.

While Executive is employed by the Company during the Term, Executive shall conduct her duties and
responsibilities hereunder from the executive offices located in Rockville, Maryland (except for
routine and customary business travel), or from such other location as approved by the Executive
Committee, pursuant to a schedule consistent with past practice or as modified by the Executive
Committee upon the consent of Executive.

3. Compensation

     a. Base Salary. While the Company employs the Executive during the Term, the Company
shall pay to Executive an annual base salary (“Base Salary”) of no less than $200,000,
payable in accordance with the Company’s customary payroll policy for its executives.

     b. Base Salary Adjustments. Executive’s Base Salary shall be reviewed at least
annually in accordance with the Company’s customary practices for its executives. The Board or a
committee thereof may make such adjustments, as it deems appropriate in its sole discretion;
provided, however, in no event shall the Company pay Executive a Base Salary of less than $200,000,
unless the change to Executive’s Base Salary was applicable to the annual base salary of all senior
executives of the Company in substantially the same manner.

     c. Incentive Compensation. While the Company employs Executive during the Term,
Executive’s annual incentive compensation (“Incentive Compensation”) shall be targeted at
25% of base compensation, the exact amount of which shall be determined by the Board or a committee
thereof in its
sole discretion. Executive shall be eligible for Incentive Compensation commencing at the
start of the Initial Term. Such bonus, if any, shall be paid within ninety (90) days following the
last day of each fiscal year of the Company.

 

 

     d. Certain Other Benefits. Throughout the Term, Executive shall be entitled to
participate in any and all employee benefit plans and arrangements which are available to senior
executive officers of the Company, including without limitation, group medical, disability and life
insurance plans, and Company’s Directors and Officers (D&O) insurance policy. Executive shall also
be afforded no fewer than twenty-three (23) days paid time off (PTO) pursuant to policies fixed by
the Company.

     e. Expenses. The Company shall continue to pay or reimburse Executive for all
reasonable business expenses actually paid or incurred by Executive, consistent with past practice
with respect to Executive, while Executive is employed by the Company during the Term, subject to
reasonable documentation and in accordance with the Company’s business expense reimbursement
policy.

4. Term.

The term of this Agreement shall be the period commencing on January 1, 2009 and continuing for one
year (the “Initial Term”); provided, however, that the Term of this Agreement shall be
extended automatically for successive one year periods (each one-year extension a “Successor
Term” and together with the Initial Term referred to herein as the “Term”) unless
written notice of nonextension is provided by either party to the other party at least sixty (60)
days prior to the end of the Initial Term or any Successor Term. In the event that this Agreement
is not extended at the end of the Initial Term or any Successor Term and thereby terminates, only
paragraphs 6, 7, 8(d), 8(g), 8(h), 8(i) and 11 shall survive such termination, except that
Executive shall be entitled to receive compensation and benefits to the extent expressly provided
herein or by the terms of any of the Company’s compensation and benefit plans, programs or policies
or as required by applicable law.

5. Stock Options.

On January 27, 2009, the Company granted stock options to Executive covering 140,000 shares of
common stock with a per share exercise price equal to the closing price of the Company’s stock on
the date of grant. Such options will vest as to 25% of the covered shares on the date of grant,
and shall vest as to the remaining covered shares in cumulative 25% share increments on each of the
first, second, and third anniversary of the date of grant, if Executive is then employed by the
Company. Other periodic stock and incentive stock option grants to Executive, if any, while the
Company employs Executive during the Term shall be determined by the Board or a committee thereof
in its discretion. In the event of a termination pursuant to paragraph 8(d) hereof or a resignation
pursuant to paragraph 9 hereof, for which purposes sections 10(a) and 10(c) of this Agreement shall
control, all vested options held by Executive on the effective date of such termination or
resignation shall be exercisable in accordance with the terms of such grants until the later of the
date set forth in such grant or twelve (12) months following Executive’s date of termination, but
in no event beyond the expiration date of the relevant option. Upon a change in control, as defined
in the option agreement, all unvested options shall vest and become exercisable immediately in
accordance with the terms of the option agreement. All other unvested options shall expire in
accordance with the terms of such grants. Except as set forth herein, the terms of the stock option
grants under this paragraph 5 shall be otherwise in accordance with and subject to the terms of the
Company’s 2001 Long Term Incentive Plan or successor plan and such terms and conditions as the
Board or a committee thereof may specify.

2

 

6. Unauthorized Disclosure.

During the Term and at all times thereafter, Executive shall not, without the written consent of
the Company, or except as required by applicable law, disclose to any person, other than a person
to whom disclosure is reasonably necessary or appropriate in connection with the performance by
Executive of her duties as an executive officer of the Company, any material confidential
information obtained by Executive while in the employ of the Company with respect to the businesses
of the Company or any of its subsidiaries, including but not limited to, operations, pricing,
contractual or personnel data, products, discoveries, improvements, trade secrets, license
agreements, marketing information, suppliers, dealers, principles, customers, or methods of
distribution, or any other confidential information the disclosure of which Executive knows, or in
the exercise of reasonable care should know, will be damaging to the Company; provided, however,
that confidential information shall not include any information known generally to the public or to
persons in the industry of which the Company’s business is a part (in each case, other than as a
result of unauthorized disclosure by Executive) or any information otherwise considered by the
Company not to be confidential.

7. Indemnification. 

     a. The Company shall defend, indemnify and hold harmless Executive if she is made a party, or
threatened to be made a party, to any threatened, pending or completed action, suit or proceeding,
whether civil, criminal, administrative, or investigative (a “Proceeding”), because she is
or was an officer or director of the Company or any of its subsidiaries, affiliates, or successors,
or because she is or was serving in a fiduciary capacity with respect to employee benefit plans of
the Company, whether or not the basis of such Proceeding is alleged action in an official capacity
or otherwise, against all Expenses incurred or suffered by her in connection with such Proceeding
to the fullest extent authorized by the General Corporation Law of the State of Delaware and any
other applicable law in effect from time to time, and such indemnification shall continue as to
Executive even if she ceases to be an officer or director or is no longer employed by the Company,
and shall inure to the benefit of Executive’s heirs, executors and administrators.

     b. As used in this Agreement, the term “Expenses” shall include, without limitation, damages,
losses, judgments, liabilities, fines, penalties, excise taxes, settlements and reasonable costs,
reasonable attorneys’ fees, reasonable accountants’ fees, and reasonable disbursements and costs of
attachment or similar bonds, investigations, and any reasonable expenses of establishing a right to
indemnification under this Agreement.

     c. Expenses incurred by Executive in connection with any Proceeding shall be paid by the
Company upon presentation of appropriate documentation and a giving by Executive of any
undertakings required by applicable law.

3

 

8. Termination.

     a. Upon Death. If Executive dies while employed by the Company during the Term, her
estate shall be entitled to receive payment of Base Salary through the last day of the six (6)
months following the month in which her death occurred, payable over six (6) months at the
Company’s normal pay periods. If, in respect of the fiscal year in which Executive dies the Board
or a committee thereof determines in its discretion that he would otherwise have been entitled to
receive Incentive Compensation under subparagraph 3(c) by reason of the operations of the Company
during such fiscal year, Executive’s estate shall be entitled to receive a pro rata portion of her
Incentive Compensation for such fiscal year. Such pro rata portion shall equal the product of (x)
the full amount of such Incentive Compensation, and (y) a fraction, the numerator of which is the
number of days in the fiscal year of Executive’s death prior to the date of death, and the
denominator of which is the total number of days in such fiscal year.

     b. Termination Upon Disability. The Company may terminate Executive’s employment
hereunder during the Term at the end of any calendar month in the event of her Disability by giving
to Executive written notice of termination. In the event of any such termination pursuant to this
subparagraph 8(b), Executive shall be entitled to receive her Base Salary, payable in accordance
with the Company’s customary payroll policy for it executives, through the last day of the six (6)
months following the month in which the date of termination occurred. If in respect of the fiscal
year in which Executive’s employment terminates pursuant to this subparagraph 8(b) the Board or a
committee thereof determines in its discretion that he would otherwise have been entitled to
receive Incentive Compensation under subparagraph 3(c) by reason of the operations of the Company
during such fiscal year, Executive shall be entitled to receive a pro rata portion of her Incentive
Compensation for such year. Such pro rata portion shall equal the product of (x) the full amount
of such Incentive Compensation, and (y) a fraction, the numerator of which is the number of days in
the fiscal year of Executive’s termination on account of Disability prior to the date of
termination, and the denominator of which is the total number of days in such fiscal year.

     c. Termination for Cause. The Company may terminate Executive’s employment hereunder
at any time during the Term for Cause by giving to Executive written notice of termination that
specifies the reasons for and date of termination, subject to the terms of sub-paragraph 10(a)
hereunder. Upon any such termination for Cause under this subparagraph 8(c), the Company shall pay
to Executive Base Salary through the date of termination, including the benefits provided at
paragraph 3(d), and the Company shall have no further obligations under this Agreement.

     d. Termination Without Cause. The Company may terminate Executive’s employment with
the Company at any time during the Term, for any reason and without Cause, by giving her written
notice thirty (30) days prior to the date of termination. Until the effective date of any such
termination, the Company shall continue to pay to Executive the full compensation specified in this
Agreement, including the benefits provided at paragraph 3(d). Following the date of termination,
Executive shall make herself reasonably available to members of the Board and other senior managers
and officers of the Company to assist in the transition of responsibilities and information to
others and to facilitate the orderly conduct of business operations. Upon termination, the Company
shall have no other financial obligations to Executive under any compensation or benefit plan,
program or policy and Executive’s participation in the Company’s compensation and benefit plans,
programs and policies shall cease as of the date of Executive’s termination except as set forth
herein or as expressly provided under the terms of any such plans, programs or policies, or as
required by applicable law. However, in addition to the above, if Executive is terminated (i)
pursuant to this subparagraph 8(d) or (ii) the Term is not extended in accordance with Section 4
and for any reason other than Cause, the Company shall (i) pay Executive a severance amount equal
to six (6)) months Base Salary over the following six (6) months at the Company’s normal pay
periods, and (ii) provide Executive coverage under the Company’s health
insurance program, under the same terms as are available to other senior executive officers of the
Company, for a period of six (6) months, after which Executive would be eligible for COBRA
continuation coverage, or until she has obtained substantially equivalent new coverage, as
determined by the Board or a committee thereof in its discretion, through successor employment,
whichever occurs sooner.

4

 

If, in respect of the fiscal year in which Executive’s employment
terminates pursuant to this subparagraph 8(d), the Board or a committee thereof determines in its
discretion that she would otherwise have been entitled to receive Incentive Compensation under
subparagraph 3(c) by reason of the operations of the Company during such fiscal year, Executive
shall be entitled to receive a pro rata portion of her Incentive Compensation for such year. Such
pro rata portion shall equal the product of (x) the full amount of such Incentive Compensation, and
(y) a fraction, the numerator of which is the number of days in the fiscal year of Executive’s
termination without Cause prior to the date of termination, and the denominator of which is the
total number of days in such fiscal year.

     e. Resignation for Other than Good Reason. Executive may voluntarily terminate her
employment with the Company during the Term for any reason upon at least thirty (30) days prior
written notice, which specifies the effective date of termination. Until the effective date of
such termination, the Company shall continue to pay her the full compensation specified in this
Agreement, including the benefits provided at paragraph 3(d), provided he continues to perform her
duties during this period. Thereafter, the Company shall have no further obligations to her under
this Agreement. This subparagraph 8(e) shall not apply to Executive’s resignation for Good Reason
pursuant to paragraph 9 hereof.

     f. No Mitigation. The parties hereto acknowledge and agree that, in the event
Executive’s employment with the Company is terminated pursuant to this paragraph 8, she shall not
be required to mitigate her damages by affirmatively seeking other employment. Further, except as
provided in subparagraph 8(d)(ii) above, the amount of any payment or benefit provided for in this
Agreement shall not be reduced by any compensation earned by her or benefit provided to her as the
result of employment by another employer or otherwise.

     g. Non-Competition. For the period of (i) twelve (12) months after resignation for
other than for Good Reason, or (ii) six (6) months after termination of employment with the Company
for any other reason, Executive shall not, as an individual, principal, agent, employee, consultant
or otherwise, directly or indirectly, or with respect to any company or entity with which the
Company has concluded partnership, licensing, joint research and development or other similar
business agreements during her employment with the Company, render any services to any firm or
company or any division or subsidiary of any firm or company, engaged in the development or
commercialization of compounds, analogs or derivatives of those compounds that (a) are of a similar
type, that is, small molecules, (for example, but not limited to, small peptidomimetic molecules),
(b) have more than one mechanism of action and cellular pathway in common with; and (c) are within
the same field (i.e. oncology or inflammation) as, those being developed and or
commercialized by the Company during the Term (“Competing Company”). In addition, for an
additional period of six (6) months after the six-month period set forth above and subject to
Section 6 hereof, Executive only may provide services to such a Competing Company if Executive does
not work on, or furnish confidential information regarding, any matter related to such compounds
defined above. Moreover, for a period of twelve (12) months after the termination of Executive’s
employment with the Company, Executive shall not take any action, without the prior written consent
of the Company, to assist Executive’s successor employer or any other entity in recruiting or
hiring any other employee who was an employee of the Company during Executive’s employment. This
prohibition includes (i) identifying to such successor employer or its agents or such other entity,
the person or persons who have special knowledge concerning the Company or its inventions,
processes, methods or confidential affairs, and (ii) commenting to Executive’s successor employer
or its agents or such other entity about the quantity or work, quality of work, special knowledge
or personal characteristics of any
person who is still employed by the Company. Executive also agrees that he will not provide such
information to a prospective employer or to an executive search firm during interviews preceding
possible employment.

5

 

     h. Non-Disparagement. During the Term and thereafter, Executive shall not communicate
negatively about or otherwise disparage the Company or its products or each and any of the released
parties described in subparagraph 8(i) in any way whatsoever except as may be required for truthful
sworn testimony or in connection with a legal or administrative proceeding, report, claim or
dispute. The Company, acting in its official capacity, shall not make any public false, disparaging
or derogatory statements in connection with or concerning Executive’s service to the Company except
as may be required for truthful sworn testimony or in connection with a legal or administrative
proceeding, report, claim or dispute. After termination, in the event Executive materially breaches
any of the conditions set forth herein or in any other paragraph of this Agreement, the Company may
discontinue the provision of any payment or benefits to her under this Agreement, and in such event
she shall forfeit her entitlement to any further termination payments or benefits under this
Agreement. After termination, in the event the Company materially breaches any of the conditions
set forth herein or in any other paragraph of this Agreement, the Executive may pursue any remedies
available to her at law.

     i. Release. In consideration of Executive’s receipt of severance benefits subject to
and in accordance with subparagraphs 8(b) and (d) and paragraph 9 of this Agreement, Executive
agrees that, upon her first receipt and acceptance of any such benefits, she shall have released
and forever discharged the Company, its subsidiaries and affiliates, successors and assigns,
predecessors and all of their respective officers, directors, employees and agents and employee
benefits plans from all claims, demands, liabilities and causes of action arising out of facts or
occurrences arising or occurring at any time up to and including the time of Executive’s
termination or resignation, whether known or unknown, and the parties hereto contemplate that this
release shall be broadly construed.

9. Resignation for Good Reason.

If Executive has Good Reason during the Term, Executive may resign at any time during the Term by
providing at least thirty (30) days prior written notice to the Company that specifies the reason
for, and the effective date of, her resignation. If Executive resigns during the Term for Good
Reason, such resignation shall be deemed a Termination without Cause under subparagraph 8(d) hereof
and Executive shall receive the compensation and benefits provided under subparagraph 8(d) hereof
as if she had been terminated without Cause.

10. Definitions.

     a. “Cause” shall mean Executive’s (i) habitual drunkenness or drug addiction, (ii) material
failure to perform and discharge her duties and responsibilities hereunder, (iii) misconduct that
is materially and significantly injurious to the Company, (iv) conviction of a felony involving the
personal dishonesty of Executive or moral turpitude, (v) conviction of any crime or offense
involving the property of the Company or (vi) material breach of Executive’s obligations under this
Agreement, provided, however, with regard to Section 10(a)(ii) and 10(a)(vi) above, the parties
exclude for this purpose an action not taken in bad faith that is remedied by Executive promptly
upon receipt of written notice thereof given to the Company.

     b. “Disability” shall mean the Executive’s incapacity due to physical or mental illness which
prevents the proper performance of Executive’s duties as set forth herein or established pursuant
hereto for ninety (90) days in any twelve (12) month period of the Term. A qualified independent
physician mutually selected by the Company and the Executive shall determine any questions as to
the existence or extent of illness or incapacity of Executive, upon which the Company and Executive
cannot
agree. The determination of such physician certified in writing to the Company and to the
Executive shall be final and conclusive for all purposes of this Agreement. For purposes of the
disability provisions of this Agreement, if the Executive is unable to act on her own behalf due to
incapacity, any person legally authorized to do so may act on the Executive’s behalf.

6

 

     c. “Good Reason” shall mean the occurrence of any of the following events during the Term:
(A) the assignment to Executive of any duties inconsistent in any material respect with Executive’s
position, authority, duties or responsibilities as of the commencement of the Term or any other
action by the Company which results in a diminution in any material respect in such position,
duties or responsibilities, excluding for this purpose an isolated and inadvertent action not taken
in bad faith that is remedied by the Company promptly after receipt of written notice thereof given
by Executive; (B) a reduction by the Company in Executive’s annual Base Salary as in effect on the
date hereof or subsequently in effect hereunder, except as agreed to by Executive, unless such
change was applicable to all senior executives of the Company; (C) the failure by the Company to
continue to provide Executive with benefits substantially similar to those enjoyed by her under any
of the Company’s pension, life insurance, medical, health and accident, disability or other welfare
plans in which he was participating as of the commencement of the Term or subsequently in effect
hereunder, unless such change was applicable to all senior executives of the Company; (D) the
failure by the Company to pay to Executive any deferred compensation when due under any deferred
compensation plan or agreement applicable to her; (E) the failure by the Company to honor in any
material respect the terms and provisions of this Agreement; or (F) a requirement by the Company
that Executive conduct her duties and responsibilities from a permanent location more than fifty
(50) miles from the place of employment, as defined in paragraph 2 herein.

11. Miscellaneous.

     a. Assignments and Binding Effect. The respective rights and obligations of the
parties under this Agreement shall be binding upon the parties hereto and their heirs, executors,
administrators, successors, and assigns, including, in the case of the Company, any other
corporation or entity with which the Company may be merged or otherwise combined and, in the case
of Executive, her estate or other legal representatives.

     b. No Assignment of Benefits. Except as otherwise provided herein or by applicable
law, no right or interest of the Executive under this Agreement shall be assignable or
transferable, in whole or in part, either directly or by the operation of law or otherwise,
including without limitation execution, levy, garnishment, attachment, pledge or in any manner; no
attempted transfer thereof shall be effective.

     c. Governing Law. This Agreement shall be governed as to its validity, interpretation
and effect by the laws of the State of Maryland, without reference to its conflict of laws
provisions.

     d. Severability. In the event that any provision or portion of this Agreement shall
be determined to be invalid, illegal, or unenforceable for any reason, the remaining provisions and
portions of this Agreement shall remain in full force and effect to the fullest extent permitted by
law. Such invalid, illegal or unenforceable provision(s) shall be deemed modified to the extent
necessary to make it (them) valid, legal, and enforceable.

     e. Withholding. All amounts payable hereunder shall be paid net of any applicable
withholding required under federal, state or local laws and any additional withholding to which
Executive has agreed.

7

 

     f. Entire Agreement; Amendments. This Agreement constitutes the entire Agreement and
understanding of the Company and Executive with respect to the terms of Executive’s employment with
the Company and supersedes all prior discussions, understandings and agreements with respect
thereto.

     g. Captions. All captions and headings used herein are for convenient reference only
and do not form part of this Agreement.

     h. Waiver. No provision of this Agreement may be modified, waived or discharged
unless such modification, waiver or discharge is agreed to in writing and signed by the Executive
and the Board or its delegate. The failure of the Company or the Executive to insist upon strict
compliance with the terms of this Agreement or the failure of the Company or the Executive to
assert any right the Company or the Executive may have hereunder shall not be deemed a waiver of
such provision or right or any other provision of this Agreement.

     f. Notice. Any notice or communication required or permitted under this Agreement
shall be made in writing and shall be delivered by hand, or mailed by registered or certified mail,
return receipt requested, first call postage prepaid, addressed as follows:

If to Executive:

Kathy Wehmeir-Davis

c/o EntreMed, Inc.

9640 Medical Center Drive

Rockville, Maryland 20850

If to the Company:

EntreMed, Inc.

9640 Medical Center Dive

Rockville, Maryland 20850

Attn.: Chief Operating Officer

     g. Counterparts. This Agreement may be executed in counterparts, each of which shall
constitute one and the same agreement.

[Remainder of Page Intentionally Left Blank]

8

 

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement effective as of January 1,
2009.

	 	 	 	 	 
	 	EXECUTIVE

 	 
	 	
 	 
	 	Kathy Wehmeir-Davis 	 
	 	 	 
	 
	 	ENTREMED, INC.

 	 
	 	By:  	 	 
	 	 	Name:  	Cynthia Wong Hu 	 
	 	 	Title:  	Chief Operating Officer,
General Counsel & Secretary 	 
	 

9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}]]